Optimization of ultrasonographic examination for the diagnosis of erosive Rheumatoid Arthritis in comparison to erosive hand Osteoarthritis.


Journal

European journal of radiology
ISSN: 1872-7727
Titre abrégé: Eur J Radiol
Pays: Ireland
ID NLM: 8106411

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 10 10 2018
revised: 18 04 2019
accepted: 08 06 2019
entrez: 24 8 2019
pubmed: 24 8 2019
medline: 31 12 2019
Statut: ppublish

Résumé

to determine thresholds and better scenario for the diagnosis of erosive rheumatoid arthritis (RA) by ultrasonography (US) in RA in comparison to osteoarthritic (OA) patients. Patients, prospectively included, fulfilling ACR 1987; ACR/EULAR 2010 criteria for RA or hand OA criteria. Radiographic assessment (RX): Sharp erosion score, evaluated by two blinded readers and one adjudicator for discordant cases (number of eroded joints ≤ three). Definition of eroded RX RA: EULAR 2013 Definition. In US, erosions were scored on six bilateral joints (MCP2-3, 5; MTP2-3, 5) with a four-grade scale. A total of 168 patients were included: 122 RA (32 early RA < 2 years; 90 late RA ≥ 2 years); 46 OA patients. On RX: 42 RA patients (6 early; 36 late) and 5 OA patients have erosive diseases (sensitivity: 34.4%, specificity: 89.1%). On US, 95 RA patients (21 early; 78 late) and 12 OA patients have erosive diseases. Considering at least two joint facets eroded (threshold 1) or at least one joint facet eroded at grade 2 (threshold 2), sensitivities were good (68 and 72.1%), specificities excellent (89.1 and 100%). With only six targeted joint facets examined (6/30), sensitivities and specificities remained good (59.8 and 60.0%) and excellent (95.6 and 100%) with threshold 1 and 2 respectively. For all scenarios, agreement between RX and US for erosive RA was excellent ranged from 88.1% to 92.8%. US erosion assessment of six targeted joint facets detected 1.7 times more erosive RA patients than RX in late and early RA with good sensitivity and excellent specificity.

Identifiants

pubmed: 31439227
pii: S0720-048X(19)30207-4
doi: 10.1016/j.ejrad.2019.06.003
pii:
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

10-18

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Camille Roux (C)

Department of Rheumatology, University Hospital of Nancy, 54500, Vandoeuvre-lès-Nancy, France. Electronic address: roux.cam@hotmail.fr.

Frédérique Gandjbakhch (F)

Department of Rheumatology, Academic Hospital Pitie Salpêtrière, Paris, France.

Audrey Pierreisnard (A)

Department of Rheumatology, Academic Hospital Pitie Salpêtrière, Paris, France.

Marion Couderc (M)

Department of Rheumatology, University Hospital of Clermont- Ferrand, Clermont- Ferrand, France.

Cédric Lukas (C)

Department of Rheumatology, University Hospital of Lapeyronie, Montpellier, France.

Racha Masri (R)

Department of Rheumatology, University Hospital of Nancy, 54500, Vandoeuvre-lès-Nancy, France.

Jean-Philippe Sommier (JP)

Department of Rheumatology, University Hospital of Nancy, 54500, Vandoeuvre-lès-Nancy, France.

Isabelle Clerc-UrmeS (I)

Platform of Clinical Research Support PARC (MDS unity), University Hospital of Nancy, 54500, Vandoeuvre-lès-Nancy, France.

Cédric Baumann (C)

Platform of Clinical Research Support PARC (MDS unity), University Hospital of Nancy, 54500, Vandoeuvre-lès-Nancy, France.

Isabelle Chary-Valckenaere (I)

Department of Rheumatology, University Hospital of Nancy, 54500, Vandoeuvre-lès-Nancy, France; INSERM, CIC-EC CIE6, Nancy, France University Hospital of Nancy, Epidemiology and Clinical Evaluation, 54500, Vandoeuvre-lès-Nancy, France.

Damien Loeuille (D)

Department of Rheumatology, University Hospital of Nancy, 54500, Vandoeuvre-lès-Nancy, France; INSERM, CIC-EC CIE6, Nancy, France University Hospital of Nancy, Epidemiology and Clinical Evaluation, 54500, Vandoeuvre-lès-Nancy, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH